ArticleThoracic cancer2022

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Ken Masubuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.